What type of study is this?

This is a Observational study (also classified as: Multi-omics profiling, Functional assays).

September 10, 2025Cell Death and DiseaseOpen Access

Profiling with senescence-associated secretory phenotype score identifies GDC-0879 as a small molecule sensitizing glioblastoma to anti-PD1

View Full Paper

Ask AI

Bookmark

Authors

This research demonstrates GDC-0879 enhances anti-PD1 efficacy in glioblastoma, indicating SASP's role in therapy.

GDC-0879 was shown to impair glioblastoma tumorigenicity and improved sensitivity to anti-PD1.
Using the SASP Score, researchers correlated tumor microenvironment changes and treatment response in glioblastoma.
The study involved multi-omics profiling of glioblastoma samples, including transcriptomic data from various datasets.
This approach underscores the significance of SASP in glioblastoma progression and potential therapeutic pathways.

Liu et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark